bandage retention cohesive heavy (Coban 1584)
bandage retention cohesive heavy risk profile, scheduling, and guidance for claims professionals and care workers . Also known as Coban 1584, Peg 7420, Peg 7422, Peg 7423, Peg 7425.
bandage retention cohesive heavy (brand names: Coban 1584, Peg 7420, Peg 7422, Peg 7423, Peg 7425) is classified as Minimal risk by AllMeds. Medical auxiliary product with no pharmacological risk.
Key Takeaways
- Risk level: Minimal (0 points)
- PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | Unscheduled | PBS listed |
Risk Profile
Medical auxiliary product with no pharmacological risk.
Regulatory and Compliance Guidance
When bandage retention cohesive heavy appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.
Australia TGA / PBS / State Schemes
Classified as Unscheduled under the Therapeutic Goods Administration (TGA).
Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.
Need to assess this medication across your caseload?
Run a full risk assessment including bandage retention cohesive heavy interactions and compliance checks.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
No credit card required. No signup for your first 2 questions.
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.